Literature DB >> 2452835

Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants.

T D Geppert1, P E Lipsky.   

Abstract

The effect of soluble or immobilized MAb directed at various additional surface proteins on the proliferation of highly purified T4 cells induced by two immobilized MAb to CD3, OKT3 and 64.1, was examined. High density 64.1 stimulated nearly all T4 cells to enter and progress through the cell cycle. Maximal T4 cell proliferation required stimulation with immobilized 64.1 throughout the length of the incubation and was not effected by any of the additional soluble or immobilized MAb employed. In contrast, low density immobilized 64.1 and all densities of immobilized OKT3 employed stimulated a minority of the cells to enter the cell cycle and proliferate. Immobilized MAb directed at CD2, class I major histocompatibility complex (MHC) encoded gene products or CD11a (LFA-1) dramatically enhanced the response, whereas soluble MAb directed at these determinants did not. Both immobilized and soluble MAb directed at CD5 and CD28 (Tp44) enhanced responses, but they were less effective than immobilized MAb to CD2, LFA-1 or HLA-A,B,C. Soluble anti-CD4 MAb inhibited responses somewhat, whereas immobilized anti-CD4 enhanced responses. Costimulation was observed when MAb to CD3 and class I MHC molecules but not CD2, LFA-1 or CD4 were immobilized to separate surfaces. The data suggest that when anti-CD3 stimulation is suboptimal, responses can be enhanced by MAb to CD5 or CD28 (Tp44) or by immobilized MAb to CD4, CD2, CD11a (LFA-1), or class I MHC encoded gene products. Although crosslinking of CD4, CD2, or CD11a with CD3 may be necessary for costimulation, immobilized MAb to CD3 and class I MHC molecules appear to deliver independent signals that result in enhanced T4 cell activation and proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452835      PMCID: PMC442582          DOI: 10.1172/JCI113481

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Flow cytofluorimetry: discrimination between single cells and cell aggregates by direct size measurements.

Authors:  T Sharpless; F Traganos; Z Darzynkiewicz; M R Melamed
Journal:  Acta Cytol       Date:  1975 Nov-Dec       Impact factor: 2.319

2.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

3.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

Authors:  T W Chang; P C Kung; S P Gingras; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

5.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

7.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.

Authors:  P Parham; W F Bodmer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

8.  Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.

Authors:  F M Brodsky; P Parham
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells.

Authors:  P J Martin; J A Hansen; R C Nowinski; M A Brown
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

10.  Identification of a human T lymphocyte surface protein associated with the E-rosette receptor.

Authors:  M Kamoun; P J Martin; J A Hansen; M A Brown; A W Siadak; R C Nowinski
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  23 in total

Review 1.  On the safety assurance of cell processing carried out in medical institutions for autologous immuno-cell therapy.

Authors:  Kohji Egawa
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

2.  A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Authors:  Robert Berland; Steven Fiering; Henry H Wortis
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

3.  Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.

Authors:  J Fleischer; E Soeth; N Reiling; E Grage-Griebenow; H D Flad; M Ernst
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

4.  The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection.

Authors:  Livia R Goes; Alia Sajani; Aida Sivro; Ronke Olowojesiku; Jocelyn C Ray; Ian Perrone; Jason Yolitz; Alexandre Girard; Louise Leyre; Constantinos Kurt Wibmer; Lynn Morris; Giacomo Gorini; Genoveffa Franchini; Rosemarie D Mason; Mario Roederer; Saurabh Mehandru; Marcelo A Soares; Claudia Cicala; Anthony S Fauci; James Arthos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-07       Impact factor: 11.205

5.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

6.  Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.

Authors:  Chinh N Tran; Steven K Lundy; Peter T White; Judith L Endres; Christopher D Motyl; Raj Gupta; Cailin M Wilke; Eric A Shelden; Kevin C Chung; Andrew G Urquhart; David A Fox
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

7.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.

Authors:  Xavier Valencia; Geoffrey Stephens; Raphaela Goldbach-Mansky; Mildred Wilson; Ethan M Shevach; Peter E Lipsky
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

8.  Altered IL-10 levels in trauma patients' M phi and T lymphocytes.

Authors:  C L Miller-Graziano; A K De; K Kodys
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

9.  Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.

Authors:  K D Bell; O Ramilo; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

10.  Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor.

Authors:  Nicholas G Minutolo; Prannda Sharma; Mathilde Poussin; Lauren C Shaw; Daniel P Brown; Erin E Hollander; Anže Smole; Alba Rodriguez-Garcia; James Z Hui; Fabiana Zappala; Andrew Tsourkas; Daniel J Powell
Journal:  J Am Chem Soc       Date:  2020-03-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.